Thu, June 3, 2010
Wed, June 2, 2010
Tue, June 1, 2010
[ Tue, Jun 01st 2010 ]: Market Wire
Covidien???????????????????
Mon, May 31, 2010
Sat, May 29, 2010
Fri, May 28, 2010
Thu, May 27, 2010
Wed, May 26, 2010
Tue, May 25, 2010
Mon, May 24, 2010
Fri, May 21, 2010
Thu, May 20, 2010

Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call

  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. -j-p-morgan-biotech-ceo-cfo-conference-call.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ Ironwood Pharmaceuticals, Inc. ] (NASDAQ: IRWD) today announced it will participate in the J.P. Morgan Biotech: CEO/CFO Conference Call Series at 10:00 a.m. Eastern Time on Friday, May 28, 2010.

Conference call details are as follows:

  • Live conference call (U.S.): (888) 889-1309
  • Live conference call (outside the U.S.): (773) 756-0161
  • Live passcode: BIOTECH
  • Replay (U.S.): (866) 501-0089
  • Replay (outside the U.S.): (203) 369-1817
  • Replay passcode: 2597

A recording of the call will be available for telephone replay for one week following the call.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood's GC-C agonist, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass.